Finance

Lists
AMRUTANJAN:NSE
Amrutanjan Health Care Ltd
510,50 INR
+0,89%
(+4,50) 1D
16 ოქტ, 11:08:29 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for AMRUTANJAN...
Open
504,50 INR
High
513,45 INR
Low
504,25 INR
Mkt. cap
14,75 მლრდ.
Avg. vol.
40,24 ათ.
Volume
7,52 ათ.
Dividend
0,96%
Quarterly dividend
1,23 INR
Ex-dividend date
11 სექ. 2026
P/E ratio
27,34
52-wk high
760,15 INR
52-wk low
476,50 INR
EPS
18,67 INR
Shares outstanding
29,23 მლნ.
No. of employees
661
Open
504,50 INR
High
513,45 INR
Low
504,25 INR
Mkt. cap
14,75 მლრდ.
Avg. vol.
40,24 ათ.
Volume
7,52 ათ.
Dividend
0,96%
Quarterly dividend
1,23 INR
Ex-dividend date
11 სექ. 2026
P/E ratio
27,34
52-wk high
760,15 INR
52-wk low
476,50 INR
EPS
18,67 INR
Shares outstanding
29,23 მლნ.
No. of employees
661
News stories
From web sources and news partners
thebambooworks.com
thebambooworks.com
·
25 წუთის წინ
Pomdoctor lands in crosshairs of Nasdaq’s ‘pump and dump’ cleanup
marketscreener.com
marketscreener.com
·
1 საათის წინ
Calm after CoreWeave shock, but for how long?
Investor's Business Daily
Investor's Business Daily
·
2 საათის წინ
Futures Mixed; Anthropic Value, Tesla Roadster In Focus
Profile
Amrutanjan Healthcare Limited is an Indian pharmaceutical company headquartered in Chennai, Tamil Nadu, India. It was founded by Kasinadhuni Nageswara Rao in Bombay in 1893. Wikipedia
About Amrutanjan Health Care Ltd
CEO-
Employees661
Founded1893
Headquartersჩენაი, ტამილნადუ, ინდოეთი
SectorPharmaceutical industry
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
1,18 მლრდ.
1,41 მლრდ.
1,50 მლრდ.
1,03 მლრდ.
Cost of goods sold
576,55 მლნ.
637,94 მლნ.
789,58 მლნ.
542,79 მლნ.
Cost of revenue
576,55 მლნ.
637,94 მლნ.
789,58 მლნ.
542,79 მლნ.
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
297,00 მლნ.
374,89 მლნ.
-186,16 მლნ.
274,66 მლნ.
Operating expense
450,77 მლნ.
537,01 მლნ.
534,06 მლნ.
463,91 მლნ.
Total operating expenses
1,03 მლრდ.
1,17 მლრდ.
1,32 მლრდ.
1,01 მლრდ.
Operating income
149,68 მლნ.
235,44 მლნ.
176,08 მლნ.
22,98 მლნ.
Other non operating income
42,96 მლნ.
41,20 მლნ.
-126,45 მლნ.
38,15 მლნ.
EBT including unusual items
192,15 მლნ.
263,64 მლნ.
210,16 მლნ.
60,69 მლნ.
EBT excluding unusual items
192,15 მლნ.
276,16 მლნ.
208,37 მლნ.
60,69 მლნ.
Income tax expense
52,53 მლნ.
69,12 მლნ.
48,23 მლნ.
17,04 მლნ.
Effective tax rate
27,34%
26,22%
22,95%
28,07%
Other operating expenses
138,19 მლნ.
145,88 მლნ.
704,15 მლნ.
170,10 მლნ.
Net income
139,62 მლნ.
194,52 მლნ.
161,93 მლნ.
43,66 მლნ.
Net profit margin
11,86%
13,79%
10,80%
4,24%
Earnings per share
-
-
-
-
Interest and investment income
-
-
159,20 მლნ.
-
Interest expense
-497,00 ათ.
-479,00 ათ.
-459,00 ათ.
-439,00 ათ.
Net interest expenses
-497,00 ათ.
-479,00 ათ.
158,74 მლნ.
-439,00 ათ.
Depreciation and amortization charges
15,58 მლნ.
16,24 მლნ.
16,06 მლნ.
19,15 მლნ.
EBITDA
165,12 მლნ.
248,47 მლნ.
189,24 მლნ.
38,78 მლნ.
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google აპები